Presenter: Dr Gert Bos – Executive Director & Partner at Qserve
The enhanced focus of the EU-MDR on biocompatibility and toxicity will be placed in perspective of the overall changes in details and concept of the European expectations. This presentation will provide some insight in the motivations to enhance the effective regulatory burden in a way that will help understand what focus should be taken for regulatory compliance.
The presentation was recorded at our Open House Event in Leuven on 4 March.
*At that time there was no consideration that the date for the enforcement of the MDR might be postponed.*
